Vericel earnings were $24.2M for the trailing 12 months ending Jun 30, 2026, with 242.9% growth year over year. The latest VCEL earnings report on Jun 30, 2026 announced Q2 2026 earnings of $2.2M, down 135% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, VCEL reported annual earnings of $16.5M, with 59.4% growth.
VCEL past earnings growth
How has VCEL's earnings growth performed historically?
On VCEL's earnings call on Jul 30, 2026, Vericel (NASDAQ: VCEL) reported Q2 2026 earnings per share (EPS) of $0.04, up 500% year over year. Total VCEL earnings for the quarter were $2.21 million. In the same quarter last year, Vericel's earnings per share (EPS) was -$0.01.
As of the last Vericel earnings report, Vericel is currently profitable. Vericel's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $24.22 million, a 240.8% increase year over year.
What was VCEL's earnings growth in the past year?
As of Vericel's earnings date in Jul 30, 2026, Vericel's earnings has grown 242.86% year over year. This is 225.41 percentage points higher than the US Biotechnology industry earnings growth rate of 17.45%. VCEL earnings in the past year totalled $24.22 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.